Program Goals

Click here to register for this event

This program is designed to improve clinical awareness of current recommendations for both carrier and newborn screening for fragile X syndrome (FXS). Historical and updated findings will be presented and discussed as they relate to benefits and challenges of population-based fragile X carrier screening.

Target Audience

Obstetricians/Gynecologists, Genetic Counselors, Mental Health Specialists, Laboratory Professionals, and those related healthcare professionals interested or involved in the clinical management of fragile x syndrome (FXS).

Educational Objectives

After completing this activity, the participant should be able to:

  1. Specify the carrier frequency for fragile X syndrome (FXS).
  2. Define the general principles of a woman’s risk to her offspring.
  3. Explain three potential benefits of prenatal carrier screening for FXS.
  4. Identify three potential benefits of newborn screening for FXS.
  5. Evaluate the major concerns that have been expressed about widespread prenatal and newborn screening for FXS.

Faculty

Thomas J. Musci, MD
San Francisco Perinatal Associates, Inc.
Associate Clinical Professor, OB/GYN and Reproductive Sciences
University of California, San Francisco  

Donald B. Bailey, PhD
Distinguished Fellow, RTI International
Research Professor, University of North Carolina at Chapel Hill

Disclosure of Conflicts of Interests

Instructors, planners, managers and other individuals who are in a position to control the content of this activity are required to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. In this activity, the faculty discloses that they will not discuss any unlabeled use of drugs, devices, or procedures nor investigational products or procedures.

Faculty Disclosures

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME and P.A.C.E.® accredited activity:

 

NAME TYPE COMMERCIAL SUPPORTER
Thomas J. Musci, MD N.A. N.A.
Donald B. Bailey, PhD N.A. N.A.

 Employees of Medical Education Collaborative, the accredited provider for this activity, and employess of Dane Garvin Ltd. have disclosed that they have no significant financial relationships.

 

Credit Designation - Physician, CME

Medical Education Collaborative designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME (ACCME) Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Collaborative (MEC) and Dane Garvin Ltd.   Medical Education Collaborative is accredited by the ACCME to provide continuing medical education for physicians.

How to Obtain CME Credit

ACCREDITATION FOR THIS ACTIVITY HAS EXPIRED

 

Viewers are expected to visit all presentations before attempting to take the test and activity evaluation. Successful completion will lead to the issuance of a certificate for 1.5 AMA PRA Category 1 Credit(s) ™. To receive credit, the course must be completed before October 1, 2008.

 If you attended the live presentation on July 31, 2007 and have received CME credit for this program, you are not eligible for additional credit.

 Participation in this activity should be completed in approximately 1.5 hours. Please follow these steps in order to receive CME credit for viewing the webcast:

  • Read all of the CME accreditation information above.
  • View the complete webcast program.
  • Click on the link to apply for CME credits.
  • Complete the online registration (registration is free).
  • Complete the online test and/or evaluation. Participants must receive a test score of at least 70% and answer all evaluation questions to receive a certificate.
  • After successfully completing the online test and evaluation, your application will be processed by the CME provider and your certificate will be sent to you. Please allow 3-4 weeks for this process.

Should you have any CME questions regarding this activity, please contact:

Medical Education Collaborative
651 Corporate Circle, Suite 104
Golden, CO 80401
866.420.3252 (toll free)
303.420.3259 (fax)
https://www.meccme.org/

Credit Designation - Lab Professional, P.A.C.E.®

The American Society for Clinical Laboratory Science's Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program will provide 1.5 contact hour of credit.

How to Obtain P.A.C.E.® Credit

ACCREDITATION FOR THIS ACTIVITY HAS EXPIRED

 

pace.jpgViewers are expected to complete the presentation before attempting to submit contact information and the session evaluation. Successful completion will lead to the issuance of a certificate for 1.5 contact hour of P.A.C.E.® approved continuing education. To receive credit, the course must be completed before October 1, 2008.

Participation in this activity should be completed in approximately 1.5 hour. Please follow these steps in order to receive P.A.C.E.® credit for viewing the webcast:

  • Read all of the information above.
  • View the complete webcast program.
  • Click on the link to apply for P.A.C.E.® credit.
  • Complete the online registration (registration is free).
  • Complete the online test and/or evaluation. Participants must receive a test score of at least 70% and answer all evaluation questions to receive a certificate.
  • After successful completion of this process, you will be redirected to the ASCLS CE Organizer where you may create and print an official ASCLS P.A.C.E.® certificate based on your attendance and completion of this ASCLS-sponsored P.A.C.E.® approved learning activity.

Should you have any P.A.C.E.® questions regarding this activity, please contact:

ASCLS P.A.C.E.®
1861 International Drive, Suite 200
Tysons Corner, VA 22102
Ph: 571-748-3776
Fx: 571-354-7576
https://www.ascls.org/

Release and Expiration

Release date: October 1, 2007
Expiration date: October 1, 2008

Fee Information

There is no fee for this educational activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Medical Education Collaborative (MEC) and Dane Garvin Ltd. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Policy on Privacy and Confidentiality

Dane Garvin Ltd. protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Dane Garvin Ltd. will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Dane Garvin, Ltd. maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Medium Used

This program has been made available online

"Is it time for Population-Based Fragile X Screening?"

System Requirements

To view this educational activity you will need a web browser with Javascript and either Flash or HTML5 enabled.  Nearly all modern web browsers will work.

Cosponsors

Cosponsored by:

AMPlogo_transp_150.gif

ACMG_logo.png

NFXF_300.jpg

 

Commercial Support Statement

Abbott_logo.png    This activity supported by an educational grant from Abbott Molecular.

Copyright

Copyright @ October 1, 2007 - Present.  Dane Garvin, Ltd.   All Rights Reserved.   Permission for accreditation use granted to Medical Education Collaborative and the American Society for Clinical Laboratory Science (ASCLS).